« Previous
Next »
Titles
- AMX0035 and oral edaravone for amyotrophic lateral sclerosis: final evidence report1
- Controversies in the management of patients with type 2 diabetes: final report1
- Ne consommez pas différents médicaments à la fois sans avis médical1
- Reducing potential overuse of dementia drugs could lead to considerable savings1
- Severely debilitating or life-threatening hematologic disorders: nonclinical development of pharmaceuticals1
- Targeted immune modulators for rheumatoid arthritis: effectiveness and value : evidence report1
- The comparative clinical effectiveness and value of simeprevir and sofosbuvir in the treatment of chronic hepatitis C infection: a technology assessment : final report1
- The therapeutic merit of combined remedies1